FI104951B - Menetelmä parenteraalisesti annettavan liposomikoostumuksen valmistamiseksi - Google Patents

Menetelmä parenteraalisesti annettavan liposomikoostumuksen valmistamiseksi Download PDF

Info

Publication number
FI104951B
FI104951B FI911501A FI911501A FI104951B FI 104951 B FI104951 B FI 104951B FI 911501 A FI911501 A FI 911501A FI 911501 A FI911501 A FI 911501A FI 104951 B FI104951 B FI 104951B
Authority
FI
Finland
Prior art keywords
cis
synthetic
formula
over
pure
Prior art date
Application number
FI911501A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI911501A (fi
FI911501A0 (fi
Inventor
Hans Georg Capraro
Peter Schneider
Hoogevest Peter Van
Ute Isele
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of FI911501A0 publication Critical patent/FI911501A0/fi
Publication of FI911501A publication Critical patent/FI911501A/fi
Application granted granted Critical
Publication of FI104951B publication Critical patent/FI104951B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Materials For Medical Uses (AREA)
  • Glass Compositions (AREA)
  • Paper (AREA)
  • Cosmetics (AREA)
FI911501A 1990-04-03 1991-03-27 Menetelmä parenteraalisesti annettavan liposomikoostumuksen valmistamiseksi FI104951B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH110490 1990-04-03
CH110490 1990-04-03

Publications (3)

Publication Number Publication Date
FI911501A0 FI911501A0 (fi) 1991-03-27
FI911501A FI911501A (fi) 1991-10-04
FI104951B true FI104951B (fi) 2000-05-15

Family

ID=4202574

Family Applications (1)

Application Number Title Priority Date Filing Date
FI911501A FI104951B (fi) 1990-04-03 1991-03-27 Menetelmä parenteraalisesti annettavan liposomikoostumuksen valmistamiseksi

Country Status (18)

Country Link
EP (1) EP0451103B1 (ja)
JP (1) JPH085793B2 (ja)
KR (1) KR910018014A (ja)
AT (1) ATE108328T1 (ja)
AU (1) AU634644B2 (ja)
CA (1) CA2039477C (ja)
DE (1) DE59102143D1 (ja)
DK (1) DK0451103T3 (ja)
ES (1) ES2056617T3 (ja)
FI (1) FI104951B (ja)
HU (1) HU208485B (ja)
IE (1) IE64990B1 (ja)
IL (1) IL97681A (ja)
NO (1) NO302735B1 (ja)
NZ (1) NZ237631A (ja)
PH (1) PH30330A (ja)
PT (1) PT97215B (ja)
ZA (1) ZA912425B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890555B1 (en) 1992-02-05 2005-05-10 Qlt, Inc. Liposome compositions of porphyrin photosensitizers
CA2087902C (en) * 1992-02-05 2006-10-17 Narendra Raghunathji Desai Liposome compositions of porphyrin photosensitizers
TW235298B (ja) * 1992-02-27 1994-12-01 Ciba Geigy
JPH0753381A (ja) * 1993-07-09 1995-02-28 Ciba Geigy Ag 局所投与可能な亜鉛フタロシアニン組成物
AU7127196A (en) * 1995-09-21 1997-04-09 Novartis Ag Nanoparticles in photodynamic therapy
US5715023A (en) * 1996-04-30 1998-02-03 Kaiser Electro-Optics, Inc. Plane parallel optical collimating device employing a cholesteric liquid crystal
US6010890A (en) * 1997-04-29 2000-01-04 New York Blood Center, Inc. Method for viral inactivation and compositions for use in same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1260393A (en) * 1984-10-16 1989-09-26 Lajos Tarcsay Liposomes of synthetic lipids
WO1988006441A1 (en) * 1987-02-23 1988-09-07 Vestar, Inc. Dehydrating vesicule preparations for long-term storage

Also Published As

Publication number Publication date
NO302735B1 (no) 1998-04-20
PT97215A (pt) 1992-01-31
ES2056617T3 (es) 1994-10-01
NZ237631A (en) 1992-12-23
JPH085793B2 (ja) 1996-01-24
EP0451103B1 (de) 1994-07-13
CA2039477C (en) 2002-09-24
ATE108328T1 (de) 1994-07-15
IE911076A1 (en) 1991-10-09
DE59102143D1 (de) 1994-08-18
HUT59009A (en) 1992-04-28
FI911501A (fi) 1991-10-04
IL97681A0 (en) 1992-06-21
NO911281D0 (no) 1991-04-02
AU7404691A (en) 1991-10-10
NO911281L (no) 1991-10-04
FI911501A0 (fi) 1991-03-27
EP0451103A1 (de) 1991-10-09
HU208485B (en) 1993-11-29
HU911070D0 (en) 1991-10-28
DK0451103T3 (da) 1994-08-15
IE64990B1 (en) 1995-09-20
PT97215B (pt) 1998-07-31
AU634644B2 (en) 1993-02-25
CA2039477A1 (en) 1991-10-04
IL97681A (en) 1996-01-31
PH30330A (en) 1997-04-02
ZA912425B (en) 1991-11-27
KR910018014A (ko) 1991-11-30
JPH04221316A (ja) 1992-08-11

Similar Documents

Publication Publication Date Title
US5466468A (en) Parenterally administrable liposome formulation comprising synthetic lipids
US5270053A (en) Parenterally administerable liposome formulation comprising synthetic lipid
ES2272496T3 (es) Procedimiento de deshidratacion/rehidritacion para la preparacion de lipososmas.
KR890004689B1 (ko) 인지질 및 미셀 입자 중에서 피포시킨 안트라사이클린 항악성종양제
CN100415210C (zh) 共冷冻干燥法制备肽/脂类络合物
JP5154296B2 (ja) 疎水性薬物のための薬物送達系
CA2442539C (en) Method and composition for solubilising a biologically active compound with low water solubility
FI86371C (fi) Foerfarande foer framstaellning av farmaceutiska liposomkompositioner.
JPH0534334B2 (ja)
JP2009507049A (ja) リン脂質のポリエチレングリコール誘導体に包み込まれたビンカアルカロイド系制癌剤のナノミセル製剤
AU2002312777A1 (en) Method and composition for solubilising a biologically active compound with low water solubility
CN1044093C (zh) 低毒性药物类脂制剂
JP2798302B2 (ja) リポソームおよび脂質複合体組成物の調製
FI104951B (fi) Menetelmä parenteraalisesti annettavan liposomikoostumuksen valmistamiseksi
NL8800231A (nl) Parenterale suspensies.
CN103040764B (zh) 一种盐酸平阳霉素脂质体注射剂
CN110575549B (zh) 一种tbFGF配体修饰的具有肿瘤主动靶向功能的脂质体及其制备方法与用途
JP2002518322A (ja) ブスルファンのリポソーム製剤

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

MA Patent expired